MCID: GLY081
MIFTS: 38

Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Categories: Liver diseases, Nephrological diseases, Metabolic diseases, Rare diseases

Aliases & Classifications for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

MalaCards integrated aliases for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency:

Name: Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency 59
Glycogen Storage Disease Type I 59 73
Glycogen Storage Disease Due to G6p Deficiency 59
Glycogen Storage Disease Type Ia 73
Glycogen Storage Disease Type 1 59
Gsd Due to G6p Deficiency 59
Hepatorenal Glycogenosis 59
Glycogenosis Type I 59
Glycogenosis Type 1 59
Von Gierke Disease 59
G6p Deficiency 59
Gsd Type I 59
Gsd Type 1 59

Characteristics:

Orphanet epidemiological data:

59
glycogen storage disease due to glucose-6-phosphatase deficiency
Inheritance: Autosomal recessive; Prevalence: 1-9/100000 (Worldwide); Age of onset: Infancy,Neonatal;

Classifications:



External Ids:

Orphanet 59 ORPHA364
UMLS via Orphanet 74 C2919796 C0017920
ICD10 via Orphanet 34 E74.0
UMLS 73 C2919796

Summaries for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

MalaCards based summary : Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency, also known as glycogen storage disease type i, is related to glycogen storage disease ia and glycogen storage disease, and has symptoms including intermittent diarrhea An important gene associated with Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency is G6PC (Glucose-6-Phosphatase Catalytic Subunit), and among its related pathways/superpathways are Glycosaminoglycan metabolism and Glucose metabolism. The drug Hypoglycemic Agents has been mentioned in the context of this disorder. Affiliated tissues include liver, testes and bone, and related phenotypes are full cheeks and xanthomatosis

Related Diseases for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Diseases related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 glycogen storage disease ia 30.9 G6PC SLC37A4
2 glycogen storage disease 9.0 G6PC SLC37A4

Symptoms & Phenotypes for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Human phenotypes related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency:

59 32 (show all 11)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 full cheeks 59 32 hallmark (90%) Very frequent (99-80%) HP:0000293
2 xanthomatosis 59 32 occasional (7.5%) Occasional (29-5%) HP:0000991
3 seizures 59 32 hallmark (90%) Very frequent (99-80%) HP:0001250
4 muscular hypotonia 59 32 hallmark (90%) Very frequent (99-80%) HP:0001252
5 hypoglycemia 59 32 hallmark (90%) Very frequent (99-80%) HP:0001943
6 hyperuricemia 59 32 hallmark (90%) Very frequent (99-80%) HP:0002149
7 recurrent respiratory infections 59 32 hallmark (90%) Very frequent (99-80%) HP:0002205
8 hyperlipidemia 59 32 hallmark (90%) Very frequent (99-80%) HP:0003077
9 short stature 59 32 hallmark (90%) Very frequent (99-80%) HP:0004322
10 cognitive impairment 59 32 hallmark (90%) Very frequent (99-80%) HP:0100543
11 recurrent infections 59 Very frequent (99-80%)

UMLS symptoms related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency:


intermittent diarrhea

Drugs & Therapeutics for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Drugs for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Hypoglycemic Agents

Interventional clinical trials:

(show all 11)
# Name Status NCT ID Phase Drugs
1 Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa) Recruiting NCT03517085 Phase 1, Phase 2
2 Diet Treatment Glucose Transporter Type 1 Deficiency (G1D) Recruiting NCT03181399 Phase 2 Triheptanoin
3 Treatment Development of Triheptanoin (G1D) Active, not recruiting NCT03041363 Phase 1 Triheptanoin
4 Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial Completed NCT02176096 Not Applicable
5 Overnight Feeding Study in Glycogen Storage Disease Type 1 Completed NCT01961076 Not Applicable
6 Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch Completed NCT02054832
7 Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease Completed NCT01854242
8 Glycogen Storage Disease Breath Test Study Recruiting NCT03218904 Not Applicable
9 Glycosade v UCCS in the Dietary Management of Hepatic GSD Recruiting NCT02318966 Not Applicable
10 Biomarker for Glycogen Storage Diseases Recruiting NCT02385162
11 Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population Terminated NCT02338817

Search NIH Clinical Center for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Genetic Tests for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Anatomical Context for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

MalaCards organs/tissues related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency:

41
Liver, Testes, Bone, Kidney, Brain, Thyroid, Bone Marrow

Publications for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Articles related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency:

(show top 50) (show all 58)
# Title Authors Year
1
Polycystic kidney features of the renal pathology in glycogen storage disease type I: possible evolution to renal neoplasia. ( 29869165 )
2018
2
Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report. ( 27900094 )
2016
3
Progressive development of renal cysts in glycogen storage disease type I. ( 27436577 )
2016
4
Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I. ( 26303612 )
2015
5
A pilot longitudinal study of the use of waxy maize heat modified starch in the treatment of adults with glycogen storage disease type I: a randomized double-blind cross-over study. ( 25758258 )
2015
6
Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation. ( 26360666 )
2015
7
Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective italian study. ( 25641239 )
2015
8
Muscle Ultrasound in Patients with Glycogen Storage Disease Types I and III. ( 26437929 )
2015
9
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study. ( 26109257 )
2015
10
Glycogen Storage Disease Type I Presenting with Hypertension During Infancy. ( 25735438 )
2015
11
Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. ( 25356975 )
2014
12
Glycogen storage disease type I: clinical and laboratory profile. ( 25019649 )
2014
13
Liver transplantation in glycogen storage disease type I. ( 24716823 )
2014
14
Regression of Hepatocellular Adenomas with Strict Dietary Therapy in Patients with Glycogen Storage Disease Type I. ( 25308557 )
2014
15
Continuous glucose monitoring in children with glycogen storage disease type I. ( 24149443 )
2014
16
Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I. ( 23412857 )
2013
17
Quality of Life in Adult Patients with Glycogen Storage Disease Type I: Results of a Multicenter Italian Study. ( 24363035 )
2013
18
Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. ( 22562700 )
2013
19
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. ( 23046672 )
2013
20
Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. ( 21416130 )
2012
21
Hypercalcemia in glycogen storage disease type I patients of Turkish origin. ( 22397040 )
2012
22
[Cardiovascular risk profile of patients with glycogen storage disease type I]. ( 21924075 )
2011
23
Natural history of hepatocellular adenoma formation in glycogen storage disease type I. ( 21481415 )
2011
24
Dietary dilemmas in the management of glycogen storage disease type I. ( 21491105 )
2011
25
Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector. ( 21730973 )
2011
26
Glycogen storage disease type I and G6Pase-I^ deficiency: etiology and therapy. ( 20975743 )
2010
27
Hypovitaminosis D in glycogen storage disease type I. ( 20060350 )
2010
28
Ischemic stroke in an adult with glycogen storage disease type I. ( 20699197 )
2010
29
Cell death and stress signaling in glycogen storage disease type I. ( 19756389 )
2009
30
Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. ( 19808227 )
2009
31
Vascular dysfunction in glycogen storage disease type I. ( 19101686 )
2009
32
Bispectral index may not reflect the depth of anaesthesia in a patient with glycogen storage disease type I. ( 19749120 )
2009
33
Emerging therapies for glycogen storage disease type I. ( 19541498 )
2009
34
Psychosocial functioning in youth with glycogen storage disease type I. ( 18296725 )
2008
35
Glycogen storage disease type I in Tunisia: an epidemiological analysis. ( 18679824 )
2008
36
Increased prevalence of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type I. ( 17307551 )
2007
37
Glycogen storage disease type I--between chronic ambulatory follow-up and pediatric emergency. ( 17410288 )
2007
38
Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. ( 17407002 )
2007
39
Glycogen storage disease types I and II: treatment updates. ( 17308886 )
2007
40
Exercise capacity and biochemical profile during exercise in patients with glycogen storage disease type I. ( 15671110 )
2005
41
Brain damage in glycogen storage disease type I. ( 15127000 )
2004
42
Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX. ( 14970741 )
2004
43
Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). ( 12373584 )
2002
44
Intestinal function in glycogen storage disease type I. ( 12227456 )
2002
45
Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. ( 12373566 )
2002
46
Glycogen storage disease type I: indications for liver and/or kidney transplantation. ( 12373572 )
2002
47
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). ( 12373567 )
2002
48
Glycogen storage disease type I: pathophysiology of liver adenomas. ( 12373570 )
2002
49
Effect of ramipril in a patient with glycogen storage disease type I and nephrotic-range proteinuria. ( 11768587 )
2001
50
Continuous glucose monitoring in children with glycogen storage disease type I. ( 11916320 )
2001

Variations for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

ClinVar genetic disease variations for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency:

6
(show top 50) (show all 172)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC37A4 NM_001467.5(SLC37A4): c.1042_1043delCT (p.Leu348Valfs) deletion Pathogenic/Likely pathogenic rs80356491 GRCh37 Chromosome 11, 118895981: 118895982
2 SLC37A4 NM_001467.5(SLC37A4): c.1042_1043delCT (p.Leu348Valfs) deletion Pathogenic/Likely pathogenic rs80356491 GRCh38 Chromosome 11, 119025271: 119025272
3 G6PC NM_000151.3(G6PC): c.379_380dupTA (p.Tyr128Thrfs) duplication Pathogenic/Likely pathogenic rs80356488 GRCh37 Chromosome 17, 41059578: 41059579
4 G6PC NM_000151.3(G6PC): c.379_380dupTA (p.Tyr128Thrfs) duplication Pathogenic/Likely pathogenic rs80356488 GRCh38 Chromosome 17, 42907561: 42907562
5 G6PC NM_000151.3(G6PC): c.247C> T (p.Arg83Cys) single nucleotide variant Pathogenic rs1801175 GRCh37 Chromosome 17, 41055964: 41055964
6 G6PC NM_000151.3(G6PC): c.247C> T (p.Arg83Cys) single nucleotide variant Pathogenic rs1801175 GRCh38 Chromosome 17, 42903947: 42903947
7 G6PC NM_000151.3(G6PC): c.883C> T (p.Arg295Cys) single nucleotide variant Pathogenic/Likely pathogenic rs104894563 GRCh37 Chromosome 17, 41063252: 41063252
8 G6PC NM_000151.3(G6PC): c.883C> T (p.Arg295Cys) single nucleotide variant Pathogenic/Likely pathogenic rs104894563 GRCh38 Chromosome 17, 42911235: 42911235
9 G6PC NM_000151.3(G6PC): c.79delC (p.Gln27Argfs) deletion Pathogenic rs80356479 GRCh37 Chromosome 17, 41052972: 41052972
10 G6PC NM_000151.3(G6PC): c.79delC (p.Gln27Argfs) deletion Pathogenic rs80356479 GRCh38 Chromosome 17, 42900955: 42900955
11 G6PC NM_000151.3(G6PC): c.*3G> A single nucleotide variant Benign/Likely benign rs191399793 GRCh37 Chromosome 17, 41063446: 41063446
12 G6PC NM_000151.3(G6PC): c.*3G> A single nucleotide variant Benign/Likely benign rs191399793 GRCh38 Chromosome 17, 42911429: 42911429
13 G6PC NM_000151.3(G6PC): c.432G> A (p.Pro144=) single nucleotide variant Benign/Likely benign rs161628 GRCh37 Chromosome 17, 41059631: 41059631
14 G6PC NM_000151.3(G6PC): c.432G> A (p.Pro144=) single nucleotide variant Benign/Likely benign rs161628 GRCh38 Chromosome 17, 42907614: 42907614
15 G6PC NM_000151.3(G6PC): c.*23T> C single nucleotide variant Benign rs2229611 GRCh38 Chromosome 17, 42911449: 42911449
16 G6PC NM_000151.3(G6PC): c.*23T> C single nucleotide variant Benign rs2229611 GRCh37 Chromosome 17, 41063466: 41063466
17 G6PC NM_000151.3(G6PC): c.340+10C> A single nucleotide variant Conflicting interpretations of pathogenicity rs368450665 GRCh37 Chromosome 17, 41056067: 41056067
18 G6PC NM_000151.3(G6PC): c.340+10C> A single nucleotide variant Conflicting interpretations of pathogenicity rs368450665 GRCh38 Chromosome 17, 42904050: 42904050
19 SLC37A4 NM_001164277.1(SLC37A4): c.*283T> C single nucleotide variant Uncertain significance rs886047746 GRCh37 Chromosome 11, 118895337: 118895337
20 SLC37A4 NM_001164277.1(SLC37A4): c.*283T> C single nucleotide variant Uncertain significance rs886047746 GRCh38 Chromosome 11, 119024627: 119024627
21 SLC37A4 NM_001164277.1(SLC37A4): c.*139G> T single nucleotide variant Uncertain significance rs886047747 GRCh37 Chromosome 11, 118895481: 118895481
22 SLC37A4 NM_001164277.1(SLC37A4): c.*139G> T single nucleotide variant Uncertain significance rs886047747 GRCh38 Chromosome 11, 119024771: 119024771
23 SLC37A4 NM_001164277.1(SLC37A4): c.*31C> T single nucleotide variant Uncertain significance rs564775174 GRCh38 Chromosome 11, 119024879: 119024879
24 SLC37A4 NM_001164277.1(SLC37A4): c.*31C> T single nucleotide variant Uncertain significance rs564775174 GRCh37 Chromosome 11, 118895589: 118895589
25 SLC37A4 NM_001164277.1(SLC37A4): c.1119C> T (p.Ala373=) single nucleotide variant Uncertain significance rs886047749 GRCh38 Chromosome 11, 119025195: 119025195
26 SLC37A4 NM_001164277.1(SLC37A4): c.1119C> T (p.Ala373=) single nucleotide variant Uncertain significance rs886047749 GRCh37 Chromosome 11, 118895905: 118895905
27 SLC37A4 NM_001164277.1(SLC37A4): c.-279C> T single nucleotide variant Uncertain significance rs886047752 GRCh37 Chromosome 11, 118901025: 118901025
28 SLC37A4 NM_001164277.1(SLC37A4): c.-279C> T single nucleotide variant Uncertain significance rs886047752 GRCh38 Chromosome 11, 119030315: 119030315
29 SLC37A4 NM_001164277.1(SLC37A4): c.*138C> T single nucleotide variant Uncertain significance rs867580827 GRCh37 Chromosome 11, 118895482: 118895482
30 SLC37A4 NM_001164277.1(SLC37A4): c.*138C> T single nucleotide variant Uncertain significance rs867580827 GRCh38 Chromosome 11, 119024772: 119024772
31 SLC37A4 NM_001164277.1(SLC37A4): c.*125G> C single nucleotide variant Benign rs8301 GRCh37 Chromosome 11, 118895495: 118895495
32 SLC37A4 NM_001164277.1(SLC37A4): c.*125G> C single nucleotide variant Benign rs8301 GRCh38 Chromosome 11, 119024785: 119024785
33 SLC37A4 NM_001164277.1(SLC37A4): c.*5A> C single nucleotide variant Uncertain significance rs373050741 GRCh38 Chromosome 11, 119024905: 119024905
34 SLC37A4 NM_001164277.1(SLC37A4): c.*5A> C single nucleotide variant Uncertain significance rs373050741 GRCh37 Chromosome 11, 118895615: 118895615
35 SLC37A4 NM_001164277.1(SLC37A4): c.-217G> A single nucleotide variant Uncertain significance rs527772065 GRCh37 Chromosome 11, 118900963: 118900963
36 SLC37A4 NM_001164277.1(SLC37A4): c.-217G> A single nucleotide variant Uncertain significance rs527772065 GRCh38 Chromosome 11, 119030253: 119030253
37 SLC37A4 NM_001164277.1(SLC37A4): c.-384G> A single nucleotide variant Uncertain significance rs886047753 GRCh37 Chromosome 11, 118901130: 118901130
38 SLC37A4 NM_001164277.1(SLC37A4): c.-384G> A single nucleotide variant Uncertain significance rs886047753 GRCh38 Chromosome 11, 119030420: 119030420
39 SLC37A4 NM_001164277.1(SLC37A4): c.-670C> T single nucleotide variant Uncertain significance rs886047754 GRCh37 Chromosome 11, 118901416: 118901416
40 SLC37A4 NM_001164277.1(SLC37A4): c.-670C> T single nucleotide variant Uncertain significance rs886047754 GRCh38 Chromosome 11, 119030706: 119030706
41 SLC37A4 NM_001164277.1(SLC37A4): c.-700+9C> T single nucleotide variant Conflicting interpretations of pathogenicity rs534659292 GRCh37 Chromosome 11, 118901550: 118901550
42 SLC37A4 NM_001164277.1(SLC37A4): c.-700+9C> T single nucleotide variant Conflicting interpretations of pathogenicity rs534659292 GRCh38 Chromosome 11, 119030840: 119030840
43 SLC37A4 NM_001164277.1(SLC37A4): c.1225G> A (p.Ala409Thr) single nucleotide variant Benign rs886047748 GRCh38 Chromosome 11, 119024975: 119024975
44 SLC37A4 NM_001164277.1(SLC37A4): c.1225G> A (p.Ala409Thr) single nucleotide variant Benign rs886047748 GRCh37 Chromosome 11, 118895685: 118895685
45 SLC37A4 NM_001164277.1(SLC37A4): c.492C> T (p.Ser164=) single nucleotide variant Uncertain significance rs369399624 GRCh37 Chromosome 11, 118898472: 118898472
46 SLC37A4 NM_001164277.1(SLC37A4): c.492C> T (p.Ser164=) single nucleotide variant Uncertain significance rs369399624 GRCh38 Chromosome 11, 119027762: 119027762
47 SLC37A4 NM_001164277.1(SLC37A4): c.382-6C> A single nucleotide variant Uncertain significance rs756248657 GRCh37 Chromosome 11, 118898588: 118898588
48 SLC37A4 NM_001164277.1(SLC37A4): c.382-6C> A single nucleotide variant Uncertain significance rs756248657 GRCh38 Chromosome 11, 119027878: 119027878
49 SLC37A4 NM_001164277.1(SLC37A4): c.-50T> G single nucleotide variant Uncertain significance rs886047750 GRCh37 Chromosome 11, 118900129: 118900129
50 SLC37A4 NM_001164277.1(SLC37A4): c.-50T> G single nucleotide variant Uncertain significance rs886047750 GRCh38 Chromosome 11, 119029419: 119029419

Expression for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Search GEO for disease gene expression data for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency.

Pathways for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

GO Terms for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

Cellular components related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 intracellular membrane-bounded organelle GO:0043231 8.96 G6PC SLC37A4
2 integral component of endoplasmic reticulum membrane GO:0030176 8.62 G6PC SLC37A4

Biological processes related to Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 steroid metabolic process GO:0008202 9.4 G6PC SLC37A4
2 glucose homeostasis GO:0042593 9.37 G6PC SLC37A4
3 cholesterol homeostasis GO:0042632 9.32 G6PC SLC37A4
4 gluconeogenesis GO:0006094 9.26 G6PC SLC37A4
5 triglyceride metabolic process GO:0006641 9.16 G6PC SLC37A4
6 glycogen metabolic process GO:0005977 8.96 G6PC SLC37A4
7 glucose-6-phosphate transport GO:0015760 8.62 G6PC SLC37A4

Sources for Glycogen Storage Disease Due to Glucose-6-Phosphatase Deficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....